BRITTANY COX: Open Payments
NPI 1992027965 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 37 payments from 19 companies in 2025. Trend: 2023 $481 · 2024 $2,734 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| DePuy Synthes Sales Inc. | 16 | $181 |
| ABBVIE INC. | 2 | $157 |
| ACADIA Pharmaceuticals Inc | 1 | $125 |
| Amneal Pharmaceuticals LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| ABIOMED | 1 | $101 |
| UCB, Inc. | 3 | $64 |
| Medtronic, Inc. | 1 | $44 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $35 |
Products named: TRUMATCH, NUPLAZID, ONGENTYS, VRAYLAR, Ozempic, Leqembi, MATRIXNEURO, ONYX 18.
Industry payments across CA — which companies pay providers there.
